Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 4/2021

12.08.2021 | Case Report

Medullary thyroid carcinoma with diabetic ketoacidosis: an autopsy case report and literature review

verfasst von: Harin Cheong, Hyun Lyoung Koo

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor of parafollicular C cells. The majority of MTCs occur sporadically, but about 30% of the cases are associated with multiple endocrine neoplasia type 2 (MEN2) syndrome or familial MTC. Generally, MTCs have no clinical manifestation, but infrequently the patients develop symptoms of hypercortisolism by secreting adrenocorticotropic hormone (ACTH) or corticotropin-releasing hormone (CRH). Although ectopic Cushing syndrome is only found in 0.7% of MTC patients, it can lead to fatal consequences if left untreated. Over 50 cases of MTC-related Cushing syndrome have been reported, and few autopsy cases exist in the literature. In those cases, the tumor cells are positive for calcitonin, but mostly display negative immunostaining for ACTH or CRH. The authors report an autopsy case of a 22-year-old woman who was found dead with no medical history whose cause of death was diabetic ketoacidosis associated with MTC, which showed poor calcitonin stainability.
Literatur
1.
Zurück zum Zitat Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567–610.CrossRef Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567–610.CrossRef
2.
Zurück zum Zitat Hoff AO, Hoff PM. Medullary thyroid carcinoma. Hematol Oncol Clin North Am. 2007;21:475–88.CrossRef Hoff AO, Hoff PM. Medullary thyroid carcinoma. Hematol Oncol Clin North Am. 2007;21:475–88.CrossRef
3.
Zurück zum Zitat Barbosa SLS, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, Caron P, et al. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid. 2005;15:618–23.CrossRef Barbosa SLS, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, Caron P, et al. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid. 2005;15:618–23.CrossRef
4.
Zurück zum Zitat Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab. 2011;96:E109–13.CrossRef Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab. 2011;96:E109–13.CrossRef
5.
Zurück zum Zitat Zhou C, Yool AJ, Nolan J, Byard RW. Armanni-Ebstein lesions: a need for clarification. J Forensic Sci. 2013;58(Suppl 1):S94–8.CrossRef Zhou C, Yool AJ, Nolan J, Byard RW. Armanni-Ebstein lesions: a need for clarification. J Forensic Sci. 2013;58(Suppl 1):S94–8.CrossRef
6.
Zurück zum Zitat Zhou C, Byard RW. Armanni-Ebstein lesions and renal epithelial cell basal subnuclear vacuolations are not the same entity. J Forensic Leg Med. 2013;20:650.CrossRef Zhou C, Byard RW. Armanni-Ebstein lesions and renal epithelial cell basal subnuclear vacuolations are not the same entity. J Forensic Leg Med. 2013;20:650.CrossRef
7.
Zurück zum Zitat Bondeson L, Ljungberg O. Occult thyroid carcinoma at autopsy in Malmö. Sweden Cancer. 1981;47:319–23.PubMed Bondeson L, Ljungberg O. Occult thyroid carcinoma at autopsy in Malmö. Sweden Cancer. 1981;47:319–23.PubMed
8.
Zurück zum Zitat Komorowski RA, Hanson GA. Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease. Hum Pathol. 1988;19:689–96.CrossRef Komorowski RA, Hanson GA. Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease. Hum Pathol. 1988;19:689–96.CrossRef
9.
Zurück zum Zitat Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol. 1988;90:72–6. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol. 1988;90:72–6.
10.
Zurück zum Zitat Thorvaldsson SE, Tulinius H, Björnsson J, Bjarnason O. Latent thyroid carcinoma in Iceland at autopsy. Pathol Res Pract. 1992;188:747–50.CrossRef Thorvaldsson SE, Tulinius H, Björnsson J, Bjarnason O. Latent thyroid carcinoma in Iceland at autopsy. Pathol Res Pract. 1992;188:747–50.CrossRef
11.
Zurück zum Zitat Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;71:4022–9. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;71:4022–9.
12.
Zurück zum Zitat Furmanchuk AW, Roussak N, Ruchti C. Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology. 1993;23:319–25. Furmanchuk AW, Roussak N, Ruchti C. Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology. 1993;23:319–25.
13.
Zurück zum Zitat Kakudo K, Miyauchi A, Ogihara T, Takai SI, Kitamura H, Kosaki G, et al. Medullary carcinoma of the thyroid. Giant cell type. Arch Pathol Lab Med. 1978;102:445–7. Kakudo K, Miyauchi A, Ogihara T, Takai SI, Kitamura H, Kosaki G, et al. Medullary carcinoma of the thyroid. Giant cell type. Arch Pathol Lab Med. 1978;102:445–7.
14.
Zurück zum Zitat Talerman A, Lindeman J, Kievit-Tyson PA, Dröge-Droppert C. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique. Histopathology. 1979;3:503–10.CrossRef Talerman A, Lindeman J, Kievit-Tyson PA, Dröge-Droppert C. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique. Histopathology. 1979;3:503–10.CrossRef
15.
Zurück zum Zitat Ruppert JM, Eggleston JC, deBustros A, Baylin SB. Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor. Am J Surg Pathol. 1986;10:513–8.CrossRef Ruppert JM, Eggleston JC, deBustros A, Baylin SB. Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor. Am J Surg Pathol. 1986;10:513–8.CrossRef
16.
Zurück zum Zitat Saad MF, Fritsche HA Jr, Samaan NA. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. J Clin Endocrinol Metab. 1984;58:889–94.CrossRef Saad MF, Fritsche HA Jr, Samaan NA. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid. J Clin Endocrinol Metab. 1984;58:889–94.CrossRef
17.
Zurück zum Zitat Bessho T. Immuno-histochemical study of medullary thyroid carcinoma. Nihon Geka Gakkai Zasshi. 1987;88:872–84.PubMed Bessho T. Immuno-histochemical study of medullary thyroid carcinoma. Nihon Geka Gakkai Zasshi. 1987;88:872–84.PubMed
18.
Zurück zum Zitat Kristiansen MT, Rasmussen LM, Olsen N, Asa SL, Jørgensen JOL. Ectopic ACTH syndrome: discrepancy between somatostatin receptor status in vivo and ex vivo, and between immunostaining and gene transcription for POMC and CRH. Horm Res. 2002;57:200–4.PubMed Kristiansen MT, Rasmussen LM, Olsen N, Asa SL, Jørgensen JOL. Ectopic ACTH syndrome: discrepancy between somatostatin receptor status in vivo and ex vivo, and between immunostaining and gene transcription for POMC and CRH. Horm Res. 2002;57:200–4.PubMed
Metadaten
Titel
Medullary thyroid carcinoma with diabetic ketoacidosis: an autopsy case report and literature review
verfasst von
Harin Cheong
Hyun Lyoung Koo
Publikationsdatum
12.08.2021
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 4/2021
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-021-00407-8

Weitere Artikel der Ausgabe 4/2021

Forensic Science, Medicine and Pathology 4/2021 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie